Office of Research & Development |
|
Project Number: | I01CX001917-01 |
Title: | Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment ofVeterans with Posttraumatic Stress Disorder (PTSD) |
Principal Investigator: | Thomas C. Neylan |
Location: | San Francisco, CA |
Congressional District Code: | 12 |
Research Service: | Clinical Science R&D |
Project Period: | January 2022 - December 2024 |
FY 2025 Funding Amount: | $47,897 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |